Zemiglo 50 mg Tablet 14's

Zemiglo 50 mg Tablet 14's belongs to the class of 'anti-diabetic medicines' primarily used to improve blood sugar control in adults with type 2 diabetes mellitus (non-insulin-dependent diabetes). Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance), or the pancreas (an organ behind the stomach) produces little or no insulin at all.

Zemiglo 50 mg Tablet 14's contains Gemigliptin that belongs to the class of 'dipeptidyl peptidase-4 (DPP-4) inhibitors'. Gemigliptin works by increasing incretin hormones that stimulate a decrease in blood glucose levels. It also decreases glucagon secretion, which raises the concentration of glucose levels. Thus, it reduces postprandial hyperglycemia (a rise in blood sugar levels after meals).

Your doctor will decide the dose and duration based on your medical condition. Some common side effects of Zemiglo 50 mg Tablet 14's include headache, nausea, diarrhoea, stomach discomfort, constipation, and dry mouth. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor. 

Before starting Zemiglo 50 mg Tablet 14's, let your doctor know if you have a history of heart, kidney or liver diseases. Do not take or stop this medicine if the doctor did not advise you. It is advised to limit your alcohol intake while using Zemiglo 50 mg Tablet 14's to avoid low blood sugar levels further. Pregnant and breastfeeding women should consult their doctor before starting Zemiglo 50 mg Tablet 14's. Zemiglo 50 mg Tablet 14's may cause hypoglycaemia (low blood sugar levels), affecting your driving ability; hence drive or operate machinery only when you feel better. Zemiglo 50 mg Tablet 14's is not recommended for children and adolescents under 18 years of age.

Zemiglo 50 mg Tablet 14's comprises 'Gemigliptin.' It increases incretin hormones that stimulate a decrease in blood glucose levels. It also decreases glucagon secretion, which raises the concentration of glucose levels. Thus, it improves glycemic control in postprandial hyperglycemia.

• Headache
• Nausea
• Diarrhoea
• Stomach discomfort 
• Constipation
• Dry mouth 

Brief your medical history to the doctor if you have any heart, kidney or liver diseases or type 1 diabetes before starting Zemiglo 50 mg Tablet 14's. It is advised to limit your alcohol intake while using Zemiglo 50 mg Tablet 14's to avoid any interactions or worsening of side effects. Pregnant and breastfeeding women should consult their doctor before starting this medication. Zemiglo 50 mg Tablet 14's may cause hypoglycaemia; hence drive and operate machinery only when you feel better. This medicine is not recommended for children and adolescents under 18 years of age.

• KETOCONAZOLE
• RIFAMPICIN

It is advised to monitor your blood sugar levels regularly.

• Maintain a fibre-rich diet and include healthy carbohydrates from fruits, vegetables and whole grains to maintain blood glucose levels.
• Eat at regular intervals.
• Monitor your weight and exercise regularly to keep your heart healthy.
• Your doctor also guides you on noticing and managing the early symptoms of high/low blood sugar levels.
• Gastrointestinal side effects can be managed with simple modifications in your lifestyle. These include cutting down on sugars and fatty foods and avoiding carbonated drinks and foods that cause gas.